kbvresearch

Companion Diagnostics Market to reach a market size of $6.5 billion by 2025

Press release   •   Oct 09, 2019 11:03 IST

According to a new report Global Companion Diagnostics Market, published by KBV Research, The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.

The Polymerase Chain Reaction (PCR) market dominated the Global Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 20.3% during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 19.1% during (2019-2025).

The Oncology market dominated the Global Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 21.1 % during the forecast period. The Neurology market is expected to witness a CAGR of 18.3% during (2019-2025).

The North America market dominated the Global Lung Cancer Companion Diagnostics by Region in 2018, growing at a CAGR of 21.7 % during the forecast period. The Europe market is expected to witness a CAGR of 19.9% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 23.5% during (2019-2025).

Full Report: https://www.kbvresearch.com/companion-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.

Global Companion Diagnostics Market Segmentation

By Technology

Immunohistochemistry

Polymerase chain reaction (PCR)

Next generation sequencing (NGS)

In Situ Hybridization and

Other Technology

By Indication

Oncology

Neurology and

Other Indications

By Cancer Type

Breast Cancer

Colorectal Cancer

Lung Cancer

Blood Cancer and

Other Cancer Type

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Australia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

Agilent Technologies, Inc.

Almac Group

ARUP Laboratories, Inc.

Abbott Laboratories (Abbott Laboratories Molecular, Inc.)

Danaher Corporation

Thermo Fisher Scientific, Inc.

Hologic, Inc.

Novartis AG

Illumina, Inc.

Qiagen N.V.

Companion Diagnostics Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Over the years, Market research has been an important component of strategic decision making processes. Market research activities have been facilitating the search for new market opportunities, understanding the market gap, bringing in the key insights into the R & D departments, value addition to marketing and promotional functions and many more. In short, one can say that the market research has been a fog light to various industries, especially while taking strategic decisions.

KBV Research is Knowledge Based Value Research, which is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals. KBV Research is a global market research and consulting company offering syndicated and custom market research reports with exhaustive industry analysis.